1. Home
  2. AQMS vs RGNT Comparison

AQMS vs RGNT Comparison

Compare AQMS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$4.00

Market Cap

12.8M

Sector

Industrials

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$2.13

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AQMS
RGNT
Founded
2014
2004
Country
United States
Israel
Employees
N/A
8
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
11.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
AQMS
RGNT
Price
$4.00
$2.13
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
54.5K
22.8K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$600.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.82
52 Week High
$39.37
$8.35

Technical Indicators

Market Signals
Indicator
AQMS
RGNT
Relative Strength Index (RSI) 38.01 37.64
Support Level $3.49 N/A
Resistance Level $4.40 $3.35
Average True Range (ATR) 0.35 0.23
MACD -0.14 0.02
Stochastic Oscillator 10.33 40.79

Price Performance

Historical Comparison
AQMS
RGNT

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: